These early findings predict that the discovery could facilitate the development of a new T-cell cancer therapy that would target and destroy a range of cancer types without the limitations of current T-cell therapies that require tailoring to the patient.
CRISPR-Cas9 Screening identifies new T-cell
A research team led by scientists at Cardiff University in Wales conducted a new study where they used a genome-wide CRISPR-Cas9 screening approach to search for genes that are vital to the recognition of target cells.
